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By means of a computer search for upstream promoter elements (distal sequence element and proximal sequence
element) typical of small nuclear RNA genes, we have identified in the human genome a number of previously
unrecognized, putative transcription units whose predicted products are novel noncoding RNAs with homology to
protein-coding genes. By elucidating the function of one of them, we provide evidence for the existence of a sense/
antisense-based gene-regulation network where part of the polymerase III transcriptome could control its polymerase
II counterpart.
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Introduction
Recent advances in mammalian genome studies are bring-
ing to light the occurrence of a widespread transcription of
noncoding (nc) regions devoted to the regulation of the
protein coding genome expression [1–4]. The mechanisms of
action of these transcripts are various and of different
natures, although all of them are devoted to the regulation of
fundamental genetic pathways involved in the determination
of the cell phenotype. The concomitant evolution of non-
coding regulatory transcripts and proteins that target differ-
ent RNA:RNA or RNA:DNA complexes emphasizes the
importance of studying the regulatory processes mediated
by nucleic acid interactions. It has been demonstrated that in
both prokaryotes and eukaryotes, cis-acting RNA regulatory
regions (i.e., 39 UTRs forming secondary structures with
regulatory features or containing sequences recognized by
proteins involved in RNA stability modulation) can be
simultaneously regulated in trans by other noncoding RNAs
(i.e., microRNAs) or by protein complexes. The simultaneous
occurrence of cis- and trans-regulatory elements brings to
light the complexity of this network where the coexistence of
different ncRNAs plays a key role in the control of other
target gene expression [5]. In this context a prominent role is
played by the enlarging family of microRNAs (miRNAs) that
act at a posttranscriptional level by inhibiting the translation
of protein-coding genes [6]. The known miRNAs, similar to
protein-coding mRNAs, are synthesized as polyadenylated
precursor molecules by the RNA polymerase (pol) II tran-
scription machinery [7]. The vast majority of the tools used in
molecular biology are based on transcript collections
obtained by oligo (dT) reverse transcriptase (RT)-PCR, thus
encompassing only polyadenylated pol II products. However,
a wide contribution of nonpolyadenylated transcripts to the
human transcriptome has been revealed [8]. The role of such
transcripts in pol II transcriptome–expression regulation
remains largely unexplored.
Among the noncoding elements, one of the most inves-
tigated has been the Alu class of repetitive sequences that
represents about one-tenth of the whole human genome.
Although it is not yet possible to discern a peculiar role of Alu
sequences, their short transcripts have been shown to be
involved in several biological processes such as: RNA editing
(where Alus are preferential sites for A to I RNA editing thus
having profound implications both in gene-expression regu-
lation and in mammalian genome evolution) [9], alternative
splicing (internal exons that contain an Alu sequence are
almost always alternatively spliced) [10], chromosomal recom-
bination (the recombination between Alu elements is at the
base of genomic deletions associated with many human
genetic disorders) [11], gene-expression regulation (function-
ing as naturally occurring antisense RNAs) [12], cell-stress
response (such as heat-shock response and/or translation
inhibition) [13], and as putative miRNAs targets [14]. The
physiological role of Alus and all the other 7SL-derived
transcripts needs to be studied in more detail. In particular,
the fact that their transcription is RNA pol III–dependent
bringstolightapreviouslyunexpectedroleingene-expression
regulation of this enzyme that deserves investigation.
In this study, starting from the observation that pol III is
specialized in transcription of ncRNA genes, we addressed
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transcription units each speciﬁcally regulating one (or more)
speciﬁc pol II genes, thus constituting functional ‘‘cogene’’/
gene pairs.
Results/Discussion
In Silico Identification of a Novel Set of Small Nuclear RNA
Gene-Like Transcriptional Units in the Human Genome
To test our hypothesis we focused on pol III type 3–
extragenic promoters, which are located upstream of the
transcribed region. We screened the human genome for
regions containing the consensus sequences characteristic of
pol III type 3 promoters: the proximal sequence element (PSE)
and the distal sequence element (DSE) [15,16]. First, we tested
the PSE sequences of three well-characterized pol III type 3–
ncRNA genes (U6, H1, and 7SK) as query sequences for the
search of similar (if not equal) elements in the human genome
by using the BLAST algorithm (http://www.ncbi.nlm.nih.gov/
BLAST; under ‘‘Nucleotide’’ subsection select ‘‘short, nearly
exact matches’’ option, then pull down ‘‘Homo sapiens’’
organism database) (see Materials and Methods for sequences
used as query). While the search with U6 and 7SK PSE
sequences did not identify a signiﬁcant number of homolo-
gous regions scattered throughout the genome, the H1 PSE
element shared a high homology with 60 novel putative PSE
sequences. Among these we selected (by a BLAST analysis)
those that contained a DSE sequence element within an
arbitrarily deﬁned distance of 1,000 basepairs upstream the
PSE. In addition to the expected H1, results evidenced 31
novel putative PSE/DSE-dependent promoters characterized
by the concomitant occurrence of the PSE and the DSE
sequences within that deﬁned genomic distance. Moreover, a
detailed sequence analysis showed that the vast majority of the
distances between the PSE and a downstream TATA box or
TATA-likeelementarewithin18–22basepairs,asexpectedfor
a canonical type 3 promoter [16]. Altogether these observa-
tions were taken as preliminary indication of a functional pol
III type 3 structure of these novel promoters (Table S1).
Since our search was based on pol III type 3 promoters,
some additional features of these promoters needed to be
considered: (i) the occurrence of a PSE consensus sequence
does not identify per se a pol III type 3 promoter; that is,
rather, the result of the simultaneous occurrence at an
appropriate distance of the PSE and an A/T-rich (TATA-like)
element. Indeed, it has been clearly shown that the
occurrence of a PSE consensus that lacks a downstream A/
T-rich element makes the promoter readable by RNA pol II,
such as in the case of the U2 snRNA gene [17]. In this context,
the transcription initiation region is not relevant for the
choice of the RNA polymerase, at least in humans, although it
seems to be of fundamental importance in Xenopus [18].
Therefore, the PSE/DSE-ﬂanked, putative transcription units
identiﬁed by our search might in theory be transcribed either
by pol II or by pol III, depending on the occurrence of a
functional A/T-rich region downstream of the PSE. (ii) Pol III
transcription units are characterized by the presence of very
simple and easily recognizable termination signals, consisting
in a run of four or more consecutive T residues. We thus
searched, within the collection of DSE/PSE-containing se-
quences, for the further occurrence of a TATA-like element
downstream of the PSE and for the occurrence of a
termination signal at a signiﬁcant distance downstream of
the hypothetical transcription start site, assumed to be
located approximately 30 basepairs downstream of the TATA
element. Such a search reﬁnement revealed that most of the
newly identiﬁed sequences have features compatible with a
pol III type 3 promoter structure (Table S2).
Our in silico search was based on the H1 PSE sequence,
which was used as a query only allowing for mismatches in the
ﬁrst and last positions. The search thus likely identiﬁed only
those promoters whose structure is very similar to that of H1.
This is supported by the fact that out of H1 no other
previously known pol III type 3 promoters were found in our
search. Given the divergence among the PSE sequences of U6,
7SK, and H1, it is to be expected that the use, as a query
sequence, of a more degenerated PSE consensus, derived
from the known pol III type 3 PSE sequences, would bring to
light a considerably higher number of putative PSE-depend-
ent transcription units in the human genome.
To further characterize in silico the novel transcription
units, we arbitrarily assumed as transcribed the region
starting from the 30th nucleotide downstream of the ﬁrst
nucleotide of the predicted TATA box. In addition, a run of
at least four T residues was considered as a pol III
transcription–termination signal, although events of ‘‘read-
through’’ are possible at T4 sequences depending on sequence
context features [19,20]. While it has to be emphasized that
the transcribed region of each element of this collection
needs to be experimentally determined, we selected 32
putative novel transcripts to be subjected to additional
analysis on the basis of their in silico characterization.
To test if a common secondary structure could be a
hallmark of the novel molecules, an in silico analysis of their
secondary structure was performed by mfold algorithm
(http://www.bioinfo.rpi.edu/applications/mfold/rna/form1.cgi)
[21]. Results showed that although hairpins with short stems
(5–7 basepairs) were frequent, no shared secondary structures
were recurrent, indicating that a peculiar molecular organ-
ization is not the common hallmark of this set of noncoding
molecules. Although their averaged free energy (DG) was
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Author Summary
After the sequence of the human genome was determined, it was
immediately recognized that a large part of the regulation of the
gene expression occurring in the cells under physiological, as well as
under pathological conditions, is carried out by RNA molecules that
do not code for proteins (the ‘‘noncoding portion’’ of the genome).
Here, we focus on small RNA molecules transcribed by the RNA
polymerase III and identify a novel set of approximately 30
noncoding (nc) RNA genes. We propose that these RNA transcripts
play a key role in regulating the expression of specific protein-
coding genes transcribed by the RNA polymerase II, thus constitut-
ing an unprecedented example of cogene/gene pairs. Furthermore,
we provide evidence that the RNA polymerase III, in addition to the
well-known task in the constitutive synthesis of small RNAs (such as
5S rRNA and tRNAs), also plays a key role in the area of gene-
expression control. A detailed investigation of the function of one of
the novel ncRNA genes, called 21A, revealed that its transcript plays
a role in the control of the proliferation of some tumor cells. The
above findings significantly expand our understanding of the ncRNA
universe and open the way to further studies aimed at the
elucidation of the molecular pathways involving this novel class of
regulatory RNAs.extremely variable ( 42.7 6 41.2), a group of four transcripts
(11A, 20A, 21A, and 29A) showed a DG value signiﬁcantly
lower than all the others (DG , 100). A statistical analysis of
such DG differences was performed evidencing that the
differences between this group of transcripts (11A, 20A, 21A,
and 29A), and the rest of the pool is highly signiﬁcant
(Student’s t-test, 33 degrees of freedom, a signiﬁcance level ¼
0.1 corresponding to a p-value of 0.0001), thus keeping in line
with their physiologically functional–secondary structure
organization (Table S3).
In order to assess if the pool of transcription units was
prevalently constituted by repeats such as retroposons, we
analyzed their sequences by Repeat Masker algorithm (http://
repeatmasker.org) evidencing that: (i) only two out of 32
(6.2%) are short interspersed nucleotide elements (21A and
29A, which were marked as AluJb elements); (ii) three of them
(24A, 37A, and 38A) are part of long interspersed nucleotide
elements; (iii) two sequences (17A and 40A) contained a
mammalian interspersed repeat (MIR), and (iv) three sequen-
ces (30A, 32A, and 44A) contained different types of long
terminal repeats (Table S4). Considering that Alus, long
interspersed nucleotide elements, and MIRs constitute about
15%, 30%, and 1%–5% of the human genome, respectively,
one would have expected a higher frequency of repeats in the
pool of sequences. Altogether these observations provide
evidence that the novel PSE-dependent transcripts are not
associated to a speciﬁc class of repetitive sequences scattered
throughout the human genome, but instead they constitute a
novel heterogeneous set of type 3 promoter-driven elements.
When these noncoding sequences were used to challenge
the human genome database (BLAST analysis), it was found
that seven of them were internal to known or predicted
protein-coding genes, four being in antisense and three in
sense conﬁguration. Most of the novel sequence elements not
mapping in coding regions shared a high sequence homology
(;80%) to a pol II transcript/expressed sequence tag that
maps in a different locus (Table S5). Such homologies reached
even higher values (up to 90%), if only parts of the putative
transcripts were considered. In fact, no expressed sequence
tags entirely containing one of our transcription units were
found, so that if a sense/antisense-based regulation would
occur, it would likely be related to parts of the ncRNA
sequences, while the other part could have structural
properties that facilitate this regulatory action (perhaps by
binding speciﬁc structural proteins). Based on these obser-
vations, a novel control mechanism of gene expression could
be postulated where pol III (or pol III-like) elements act as
trans-locus antisense of their homologous protein-coding
RNAs. In this model, the pol III cogenes in antisense
conﬁguration with respect to one (or more) speciﬁc target
gene(s) could regulate their expression either by interfering
with its mRNA maturation (if the homologous region is
internal to an intron) or by inhibiting protein translation (if
the homology is associated to an exon).
21A as Cogene Experimental Model
To test our hypothesis we selected one of the novel
transcription units (here referred to as 21A) that maps in
8q24.13. If aligned to the human genome, it shows several
homology hits among which the most highly signiﬁcant were
associated to multiple intronic regions of centromeric
protein F gene (CENP-F; 1q32-q41) [22], thus constituting its
putative natural trans-chromosomal antisense (Figure 1A–1C).
Although, similarly to all of the 7SL/Alu-derived elements, 21A
is expected to be primate-speciﬁc [23], an evolutionary
conservation analysis was performed aligning its sequence
with the mouse-predicted CENP-F gene. No signiﬁcant
similarities were found indicating that in rodents a putative
CENP-F antisense regulatory role, if any, would be associated
to a different class of noncoding elements. Despite its high
sequence similarity with other human Alus, 21A lacks the Alu-
speciﬁc intragenic consensus elements needed to promote its
pol III transcription such as the blocks A and B [24]. This
observation further pointed to a 21A transcription driven by
an extragenic type 3 pol III promoter.
To check for 21A expression in cultured cells, we
performed Northern blot analysis on total HeLa cell RNA
and skin ﬁbroblast RNA using a 21A dsDNA probe. Two
positive bands were detected: one corresponding in size to
the expected 21A transcript (;300 nucleotides), and the other
one corresponding to a high molecular mass transcript (as
expected for CENP-F mRNA) (Figure 2A). However, consid-
ering that the 21A double-strand cDNA probe would detect
transcription of 21A-similar Alus from multiple loci, we also
ampliﬁed a 21A-speciﬁc cDNA from total RNA samples,
extracted from skin ﬁbroblasts and four tumor cell lines
(293T, LAN5, HCT, and HeLa), by random hexamer-based
RT-PCR in order to better identify a 21A-speciﬁc tran-
scription product (Figure 2B). The DNA band obtained was
then puriﬁed and sequenced, evidencing that the ampliﬁca-
tion product was the expected 21A. In addition, to better
assess 21A transcription, we fused its promoter region to a
luciferase silencer hairpin and cotransfected this construct
with a plasmid-expressing luciferase. Results showed a halved
luciferase activity 48 h after transfection, thus demonstrating
an efﬁcient transcription directed by 21A promoter. In the
same experiment, a set of ﬁve novel promoters from our
collection was tested, demonstrating an active transcription
of the hairpin promoted by four of them (Figure 2C). These
data support the conclusion that the majority of the novel
putative transcription units is under the control of active
extragenic PSE/TATA-containing promoters.
Pol III–Dependence of the Novel Transcription Units
The same experiment as above was repeated after 24 h of
cell treatment with ML-60218, a cell-permeable indazolo-
sulfonamide compound that displays broad-spectrum inhib-
itory activity against pol III [25]. Results showed an efﬁcient
luciferase-silencing activity in the absence of the pol III
inhibitor (as evidenced by a decreased luciferase emission),
while after treatment with ML-60218 the luciferase signal was
increased (Figure 2D). As a control, a similar experiment was
performed by treating the cells for 12 h with a pol II inhibitor
(a-amanitin). In this case, no major transcription variations
were observed either for the novel transcript units or for the
well-known pol III-dependent H1 gene (Figure 2E).
To better assess pol III dependence of 21A transcription,
we directly measured the endogenous 21A (and 29A) RNA
amount in ML-60218 treated cells versus untreated control
samples. Results evidenced a signiﬁcant transcription down-
regulation of the two novel pol III units (50% and 30%
inhibition in the case of 21A and 29A, respectively), thus
keeping in line with the occurrence of a speciﬁc effect of ML-
60218 on their promoters.
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inhibitors, we analyzed by real-time RT-PCR the transcrip-
tion activity of two pol III (5S rRNA and 7SK) and two pol II-
dependent genes (c-Myc and glyceraldehyde 3 phosphate dehydro-
genase [GAPDH]) both in ML-60218 and in a-amanitin-treated
cells. Results showed a signiﬁcant inhibition of the pol III–
dependent genes after ML-60218 treatment and a stable
transcription level of the pol II–dependent genes in the same
samples (Figure 2F). On the contrary, pol III transcription
activity was stable in a-amanitin–treated cells, while in the
same samples the pol II–transcribed genes were downregu-
lated, thus demonstrating the speciﬁcity of action of the two
inhibitors in these experimental conditions (Figure 2G).
Altogether, these results provide evidence that the novel
PSE/TATA-containing transcription units are transcribed by
pol III.
21A Acts as CENP-F Regulatory Cogene Modulating Its
Expression at Posttranscriptional Level
To test whether the 21A transcript acts as an antisense
inhibitor of CENP-F expression, we measured by Western
analysis CENP-F protein level in HeLa cells transiently
transfected with four different 21A constructs carrying: (i)
the whole 21A region containing both DSE and PSE elements
(p21A); (ii) its upstream moiety, which contains the DSE and a
MIR element, but not the CENP-F homology region (p21A-1);
(iii) the novel pol III type 3–transcription region (which
includes an Alu Jb module) (p21A-2); and (iv) an empty vector
as mock control (pMock). As shown in Figure 3, starting at 24
h from transfection of the whole 21A region, inhibition of
CENP-F accumulation (followed by a rapid degradation) was
observed. Such inhibition was speciﬁcally associated to
constructs expressing the 21A RNA (p21A, p21A-2), while the
MIR element in the upstream moiety of the fragment (p21A-1
construct) was ineffective (Figure 3A–3D).
In this context, it has to be noted that a slight delay
occurred in 21A-2 inhibitory action (and in the expression of
21A-speciﬁc RNA), compared to what was observed with the
complete 21A construct (more rapid increase in 21A RNA
expression and decrease of CENP-F protein levels), suggesting
a positive transcriptional role of the DSE element. The actual
occurrence of 21A transcription in transfected cells was
Figure 1. CENP-F as 21A-Specific Molecular Target
(A) Human CENP-F gene structure as resulting from GI:89161185 (region 212843155 - 212904537).
(B) The positions of the 21A antisense homologous regions are reported together with their percentage of identity.
(C) Sequence alignment of 21A/CENP-F homologous regions.
doi:10.1371/journal.pgen.0030001.g001
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(A) Northern blot analysis of human skin fibroblasts and HeLa cells. Results show two bands: the first (detected at about 300 nucleotides) being the 21A
endogenous product and the second (of a very high molecular mass) representing CENP-F mRNA.
(B) 21A-specific RT-PCR amplification. As expected for nonpolyadenylated transcripts, an efficient amplification product was obtained only in the
random hexamers-primed reactions.
(C) Promoter activity transfection assay. A specific luciferase-silencing hairpin is transcribed by six PSE/DSE-dependent promoter elements (11A [H1
RNA], 14A, 21A, 29A, 38A, 51A). A view of the silencing constructs including the hairpin nucleotide sequence is enclosed. The promoter region
encompasses the putative pol III type 3 regulatory regions (TATA box, PSE, and DSE). pGL3 þ pRL, negative control; pSHAG-U6, canonical pol III
promoter; No promoter, hairpin without PSE/DSE-dependent promoter thus resulting transcriptionally inactive.
(D and E) Promoter-activity transfection assay in presence/absence of 20 lM ML-60218 cell-permeable pol III inhibitor or 10 lg/ml a-amanitin pol II–
specific inhibitor. Results are reported as luciferase emission of treated versus untreated samples.
(F) Real-time RT-PCR analysis of transcript levels for 21A and 29A transcription units, two known pol III–transcribed genes (7SK and 5S rRNA), and one pol
II–transcribed gene (c-Myc) in ML-60218 treated/untreated cells, as resulting after normalization of each treated sample with its untreated counterpart.
All the measures were referred to a ML-60218 unaffected pol II housekeeping gene (GAPDH).
(G) Real-time RT-PCR analysis of the RNA level of two known pol II–transcribed (c-Myc and GAPDH) and one pol III–transcribed (7SK) genes in a-amanitin
treated/untreated cells as resulting after normalization of each treated sample with its untreated counterpart. All the measures were referred to an a-
amanitin unaffected pol III gene (5S rRNA).
doi:10.1371/journal.pgen.0030001.g002
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very high amount of 21A transcript was detected in p21A and
p21A-2–transfected cells (210- and 480-fold, respectively, at
48 h from transfection), while the 21A RNA content of
samples transfected with pMock control plasmid and/or with
a construct containing the promoter lacking the transcribed
region (p21A-1 construct) were essentially stable, showing a
very low basal level of 21A expression in untransfected HeLa
cells (Figure 3I–3N). All the PCR products were analyzed in
their dissociation curve, showing a single characteristic pick
(at 78–79 8C) in p21A/p21A2-transfected samples signiﬁcantly
reduced in pMOCK/p21A-1. On the contrary, the cells
transfected with the two control plasmids (pMock/p21A-1)
showed a dissociation pattern characteristic of a heteroge-
neous population of molecules (Figure 3O). Again these
results conﬁrmed an active synthesis of the exogenous 21A
ncRNA transcript in p21A/p21A-2–transfected samples that
was strongly reduced at a very low endogenous–basal level in
the samples lacking the transcript region (pMOCK/p21A-1).
As a consequence of 21A very active transcription, the level of
CENP-F mRNA (as determined by real-time RT-PCR) was
signiﬁcantly decreased in p21A/p21A-2–transfected cells,
while no major CENP-F mRNA variations were observed in
pMOCK/p21A-1–transfected cells (Figure 3E–3H). Altogether
these results demonstrate an inverse correlation between 21A
transcription and CENP-F expression. Therefore, considering
the high sequence homology between 21A transcript and
three CENP-F hnRNA intronic portions, we suggest a
mechanism of antisense inhibition of CENP-F mRNA matu-
ration by the 21A transcript.
21A Overexpression Specifically Inhibits Cell Proliferation
in Humans
Given the central role of CENP-F in mitosis, we tested the
effect of ectopic 21A expression on cell proliferation. By
measuring [
3H]-thymidine incorporation, we observed a
dramatic arrest of cell proliferation after 48 h in 21A-
transfected cells. Again, the effect was speciﬁcally associated
to the downstream 21A transcribed region (p21A/p21A-2
constructs), while transfection of the MIR-containing up-
stream moiety (p21A-1 construct) did not alter cell prolifer-
ation (Figure 4A). Although at the present state we cannot
exclude a contribution to this effect by Alus from other loci,
Figure 3. 21A-Driven CENP-F Expression Regulation
(A–D) 21A constructs. d, DSE Element; p, PSE Element; p21A, whole transcription unit; p21A-1, upstream, DSE-containing region; p21A-2, transcription
region; pMock, empty vector; t, TATA box.
(E–H) CENP-F protein expression level after 0, 24, 48, and 72 h of constructs transfection. Full triangle, anti-CENP-F antibody; Full circle, anti-tubulin
antibody (for protein loading normalization); Striped columns, quantitative determination of CENP-F expression modulation as determined by Western
blot analysis; Full columns, quantitative determination of CENP-F mRNA expression modulation as determined real-time RT-PCR analysis.
(I–N) 21A RNA level in transfected samples indicating that the exogenous 21A expression inversely correlates with CENP-F protein expression.
(O) Dissociation curve of 21A amplification products. A, 21A-transfected HeLa cells; B, untransfected HeLa cells showing the very low basal 21A
transcription level.
doi:10.1371/journal.pgen.0030001.g003
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(A) Proliferation inhibition of HeLa cells after 48 h of 21A constructs transfection. Results emphasize the specificity of the Alu Jb-containing region as a
source of proliferation inhibitory transcripts.
(B) Proliferation increase of HeLa cells after 48 h of pAnti-21A and si21A transfection. siEx-FABP, unrelated chicken-specific siRNA (negative control).
(C and D) Constructs structures. Anti-21A, the transcript region is inverted and the construct maintains 21A promoter as well as its termination site.
si21A, siRNA 21A-specific.
(E and F) CENP-F protein expression level after 0, 24, and 48 h of constructs transfection. Full triangle, anti-CENP-F antibody; full circle, anti-tubulin
antibody; striped columns, quantitative determination of CENP-F expression modulation as determined by Western blot analysis; full columns,
quantitative determination of CENP-F mRNA expression modulation as determined real-time RT-PCR analysis.
(G and H) 21A RNA level in transfected samples indicating that the endogenous 21A expression is inhibited after 24 h of anti-21A/si21A transfection.
doi:10.1371/journal.pgen.0030001.g004
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transcription and cell proliferation that is in accord with the
inhibition of CENP-F synthesis demonstrated above.
To further support the antisense role of 21A, we trans-
fected HeLa cells with a construct expressing the transcript in
antisense conﬁguration (here referred to as pAnti-21A), thus
quenching the activity of the endogenous 21A molecules.
Results showed an increased cell proliferation 24–48 h after
transfection. Similar results were obtained when a 21A-
speciﬁc small interfering RNA (siRNA)–expressing construct
was transfected in HeLa cells, while the negative control
sample (cells transfected with an unrelated chicken-speciﬁc
siRNA) maintained a cell-proliferation rate similar to that of
pMock-transfected cells (Figure 4B). In both of the experi-
ments an increased CENP-F expression was detected both at
the protein and mRNA levels (Figure 4E and 4F). As
evidenced by real-time RT-PCR in the same experiment, a
concomitant 21A-RNA decrease was observed after 24 h of
transfection in anti/si21A treated cells, although a complete
recovery of 21A RNA synthesis occurred after 48 h of
transfection (Figure 4G–4H). As shown in these experiments
CENP-F modulation and 21A RNA decrease were analyzed
only at 0, 24, and 48 h after transfection, rather than at 0, 24,
48, and 72 h as in the previous experiments. In fact, at 72 h
after transfection the CENP-F synthesis determinations would
be strongly biased by an early cell culture overconﬂuence
caused by the proliferation increase that follows 21A down-
regulation.
These data suggest that the decreased amount of 21A
transcript consequent to its siRNA-mediated silencing, as well
as its suppression by antisense technology, speciﬁcally
increases CENP-F synthesis, thus keeping in line with the
proposed role of 21A as CENP-F regulatory cogene. In
addition, it has to be considered that the increased
proliferation rate observed here supports the idea of a
widespread regulatory action of 21A that may control at the
posttranscriptional level the expression of several target
genes similarly to what has been proposed for miRNAs [26].
The 21A Regulatory Effect Is Human Specific
Considering that a 21A-driven cell-proliferation inhibition
is expected to be primate speciﬁc (Alu sequences were not
found in other mammalian orders), we tested for its possible
occurrence in mouse. We found that, after transfection of
p21A, p21A-1, p21A-2, and pMock, the murine ﬁbroblast NIH
3T3 cells did not show any proliferation decrease as assessed
by [
3H]-thymidine incorporation (Figure 5). The species-
speciﬁcity of 21A action, together with its inability to cause a
nonspeciﬁc cell reaction that leads to a proliferative blockade
in mice, further strengthens a 21A-speciﬁc (perhaps multi-
locus) regulatory role.
In fact, considering these data we rule out a nonspeciﬁc
effect of 21A on cell proliferation, perhaps due to the
activation of a more general biological process, such as the
interferon response (an antiviral cell reaction shared by all
mammals), rather than a speciﬁc multilocus 21A regulatory
action.
21A Endogenous ncRNA Is Downregulated in Tumor Cell
Lines
As demonstrated by transfection experiments, 21A over-
expression is inversely correlated to cell proliferation. In
accordance with this ﬁnding, its basal expression level is very
low in fully proliferating HeLa cells. To better investigate the
inverse correlation between the endogenous 21A expression
and cell proliferation, we analyzed by quantitative real-time
RT-PCR the 21A expression levels in cell types characterized
by different proliferation potentials. Results showed that in
three immortalized, fully proliferating cell lines analyzed here
(HeLa as cervical adenocarcinoma; 293T as renal epithelial
adenovirus transformed cells; LAN5 as neuroblastoma), the
level of 21A transcription was very low if compared to the
unproliferating/resting PBL (peripheral blood lymphocyte)
cells, in which a 276-fold-increased–21A transcription was
evidenced. In the same experiment, according to an inverse
correlation between endogenous 21A transcription and the
cell proliferation rate, the 21A RNA level in primary skin
ﬁbroblasts (of which the proliferation rate is signiﬁcantly
lower than that of the tumor cell lines analyzed here) showed
a 23-fold increase compared to 393 T cells, and a very low
expression level if compared to the resting/unproliferating
PBL (Figure 6). Again the dissociation curve analysis of 21A
ampliﬁcation product showed in PBL a peak at 78–79 8C,
characteristic of a single speciﬁc molecular species that
resembled the one obtained in 21A/21A-2 transfected cells
(where the amount of 21A transcripts was strongly increased),
although a slight shoulder, most likely due to a cross-
ampliﬁcation of other very similar transcripts, revealed a
detectable endogenous Alu transcription background (Figure
6). Altogether these results evidence a very active 21A
transcription in PBL/resting cells that further strengthens
the idea of 21A as a novel key factor of cell-proliferation
control.
In order to check if the endogenous 21A overexpression in
unproliferating cells was related to a widespread increased
RNA polymerase III activity rather than a 21A-speciﬁc
activation, we measured by real-time RT-PCR the 5S rRNA
expression level in the same samples. The results showed no
Figure 5. Mouse NIH-3T3 Cell Proliferation Rate after Transfection of 21A
Constructs
No proliferation decrease was observed.
doi:10.1371/journal.pgen.0030001.g005
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proliferation rate variations, evidencing that the 21A over-
expression in resting cells was the consequence of a 21A-
speciﬁc transcription activation rather than a wider, non-
speciﬁc increase of pol III activity (Figure 6). These data thus
suggest the existence of an unexpectedly speciﬁc expression
regulation of 21A promoter (related to the cell proliferation
state) that needs to be investigated in detail.
Conclusions
We propose that the noncoding fraction of the human
genome includes a larger than expected number of ncRNA
genes controlled by DSE and PSE promoter elements. Due to
their promoter structure, a number of these genes is likely to
be transcribed by pol III. We refer to them as cogenes since
they could speciﬁcally coact with a protein-coding pol II
gene. Given the very high sequence homology between pol III
and pol II transcript pairs, and in light of the results we have
obtained investigating the regulatory activity of the 21A
transcription unit, we propose that a large part of these novel
elements may act as antisense inhibitors of protein trans-
lation and/or mRNA maturation, although some of them
(those whose homology with the pol II target gene is in sense
conﬁguration) could play a role in gene-expression regu-
lation with different mechanisms. Altogether these ﬁndings
provide evidence for the existence of an ncRNA gene set
associated to PSE/DSE-containing promoters, whose products
coact with a corresponding set of protein-coding targets.
In conclusion, this study provides: (i) a collection of novel
noncoding transcripts to be investigated for their potential
regulatory action with respect to pol II target genes; (ii) a
novel source of PSE-dependent promoters useful for the
identiﬁcation of common regulatory regions speciﬁc for this
type of promoters; (iii) a novel class of molecules involved in
the RNA-dependent gene expression regulation; and (iv) a
novel transcript (21A), whose role in tumor cell proliferation
deserves further investigation in the context of cancer
studies.
Materials and Methods
Databases and searches. All of the sequence searches and align-
ments were carried out by means of BLAST at the National Center
for Biotechnology Information (http://www.ncbi.nlm.nih.gov/BLAST).
The sequences used to query were the following: H1 PSE, nCACCA-
TAAAnGTGAAAn or nTTTCACnTTTATGGTGn; U6 PSE,
CTTACCGTAACTTGAAAGT; 7SK PSE (as reported in PMID:
2011518), TTGACC-TAAGTG; DSE (Octamer-Binding Transcription
Factor 1 [Oct1] consensus sequence), ATTTGCAT or ATGCAAAT
with or without a single base of mismatch.
Cell culture, transfection, and luciferase assay. For transient
transfections, HeLa cells (grown in DMEM supplemented with 10%
FCS), were grown in multiwell petri dishes 16 h before transfection.
The expression (21A, 21A[1], 21A[2], 21A[3]) constructs containing the
regions of interest cloned in the pTopo vectors (Invitrogen, http://
www.invitrogen.com) were introduced into the cells using the Fugene
6 transfection reagent (Roche, http://www.roche.com/home.html)
according to the manufacturer’s instructions. A plasmid expressing
luciferase was used as a control of transfection efﬁciency (to which all
the results were normalized). Cells were harvested 24, 48, and 72 h
after transfection, and ﬁreﬂy luciferase activity was measured by
dual-luciferase reporter–assay system (Promega, http://www.promega.
com) according to the manufacturer’s protocol. To speciﬁcally inhibit
RNA polymerase III and/or RNA polymerase II, a cell-permeable
chlorobenzenesulfonamide (ML-60218) (Calbiochem, http://splash.
emdbiosciences.com) and/or a-amanitin (Roche, http://www.roche.
com) were used at the concentration of 20 lM and 10 lg/ml,
respectively, in the medium for 25 h (ML-60218) and 12 h (a-
amanitin) before the luciferase activity detection.
RNA interference–silencing assay. To test the promoter activity of
the novel transcription units, we prepared six plasmid constructs
expressing a ﬁreﬂy luciferase-silencing hairpin (Gregory Hannon,
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York,
United States); transcription was driven by the 11A, 14A, 21A, 29A,
38A, 51A promoters, respectively. The hairpin sequence (targeting a
ﬁreﬂy luciferase mRNA from a cotransfected expression plasmid
[Promega]) is: 59-GGAUUCCAUUCAGCGGAGCCACCUGAUGAAG-
CUUGAUCGGGUCUCGCUGAGUUGGAAUCCAUU-39. Oligos used
to subclone the novel pol III type III promoters within Not I/HinD III
restriction sites (uppercase letters) were the following:
11AFprom Not I: 59-atgcGCGGCCGCatttgcatgtcgctatgtg-39
11ARprom HinD III: 59-gatcAAGCTTcatcaggtggctcccgctgaattg-
gaatccacgcactcagctcgtg-39
14AFprom Not I: 59-atgcGCGGCCGCaactgatgtatgattatatctt-39
14ARprom HinD III: 59-gatcAAGCTTcatcaggtggctcccgctgaattg-
gaatccattattatctcctttgttctgt-39
21AFprom Not I: 59-atgcGCGGCCGCacagctgtagcagatgct-39
21ARprom HinD III: 59-gatcAAGCTTcatcaggtggctcccgctgaattg-
gaatccaccacacttggtcaactat-39
29AFprom Not I: 59-atgcGCGGCCGCttctcacctaaaggagtc-39
29ARprom HinD III: 59-gatcAAGCTTcatcaggtggctcccgctgaattg-
gaatccttctaatcctcctaagatca-39
38AFprom Not I: 59-atgcGCGGCCGCttcactaagatccagtgc-39
38Arprom HinD III: 59-gatcAAGCTTcatcaggtggctcccgctgaattg-
gaatccgattcatgaacacagaatatt39
51AFprom Not I: 59-atgcGCGGCCGCgttgaacatttaactctgtat-39
51Arprom HinD III: 59-gatcAAGCTTcatcaggtggctcccgctgaattg-
gaatccctcatggcacttggagat-39
In this analysis, the above constructs were cotransfected with a
pGL3 plasmid-expressing (Promega) ﬁreﬂy luciferase as a target to be
silenced and with a pRL plasmid expressing (Promega) renilla
luciferase to which all the determinations were normalized. Cells
were harvested 24, 48, and 72 h after transfection, and ﬁreﬂy/renilla
Figure 6. Real-Time RT-PCR Analysis of 21A Endogenous RNA in Different
Cell Types with Respect to the Less Abundant Samples (293T for 21A RNA
and Fibroblasts for 5S rRNA)
Striped columns, 21A RNA; full columns, 5S rRNA. The dissociation curve
of 21A amplification product in PBL is reported in the inset.
doi:10.1371/journal.pgen.0030001.g006
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system (Promega) according to the manufacturer’s protocol.
Plasmid constructs generation and sequencing. The plasmid
constructs p21A, p21A(1), and p21A(2) were generated amplifying
from a genomic DNA preparation of the regions of interest; the PCR
products were then subcloned into the pNEB193 vector. The oligos
used to generate p21A PCR fragments were the following:
21A forward: 59-GGAAATCTTACCTTCCTGCC-39
21A reverse: 59-TGGCTAGGTCATGTGACCAT-39
21A(1) forward: 59-GGAAATCTTACCTTCCTGCC-39
21A(1) reverse: 59-TTCATTCATTCATTCATTGATTCAC-39
21A(2) forward: 59–CAGCTGCAGCAGATGCTAGCAGGGC-39
21A(2) reverse: 59–TGGCTAGGTCATGTGACCATTC-39
The plasmid construct pAnti-21A was generated amplifying the
transcribed region from p21A plasmid using the following oligos:
Anti-21A Terminator-containing forward: 59-CTGAAAAAG-
TAGTCCCAGCACTTTG-39
Anti-21A Bam HI-containing reverse: 59-ATGCGGATCCGAGA-
CAGGGTCTTGCTC-39
Thus the transcribed region was generated in antisense conﬁg-
uration. The pAnti-21A promoter was obtained by amplifying p21A
promoter with the following oligos:
21A Forward: 59-GGAAATCTTACCTTCCTGCC-39 p21A Bam HI-
containing reverse: 59-ATGCGGATCCGAGCCACCACACTTGGTC-
39. The PCR products were digested with the restriction enzyme Bam
HI, puriﬁed by gel electrophoresis, and ligated by T4 ligase
(Invitrogen). The insert obtained was then subcloned in pTOPO
vector (Invitrogen) following the manufacturer’s instructions. Prior
to transfection all of the plasmids were sequenced by DNA
sequencing kit (Applied Biosystems, www.appliedbiosystems.com)
following the manufacturer’s instructions.
RT-PCR reactions. To isolate and sequence a partial 21A cDNA, we
performed different RT-PCR reactions. Starting from about 5 lgo f
total RNA, cDNA was synthesized by using an oligo (dT)12–18 primer
or a random hexamers mix and a superscript ﬁrst-strand synthesis
system for RT-PCR (Invitrogen). cDNAs were diluted 10–50 times,
then subjected to PCR reactions. The oligos used to isolate 21A RT-
PCR product were: oligo forward 21AF 59-gctcacgtagtcccagcacttt-39
and oligo reverse 21AR 59-actatgttgcccaagctggtct-39. PCR products
were separated on 1.5%–2% agarose gel. The DNA bands were cut,
puriﬁed by the Millipore DNA gel extraction kit (http://www.
millipore.com), and sequenced.
Real-time quantitative RT-PCR. The RNA for 21A was measured by
real-time quantitative RT-PCR using the PE ABI PRISM@ 7700
sequence detection system (PerkinElmer, http://www.perkinelmer.
com) and Sybr Green (Applied Biosytems). The sequences of 21A
forward and reverse primers as designed by the Primer Express 1.5
software (Applied Biosystems) were 59-GCTGAGGCAGGAGGAT-
CACT-39 and 59-GCACTACCACACCCAGCTAATTTT-39. The se-
quences of CENP-F forward and reverse primers were 59-
CTGCAGAAAGAACTCTCTCAACTTC-39 and 59-TCAACAAT-
TAAGTAGCTGGAACCA-39. For endogenous control, the expression
of GAPDH gene was examined. The sequences for human GAPDH
primers were 59-GAAGGTGAAGGTCGGAGTC-39 and 59- GAA-
GATGGTGATGGGATTTC-39. The sequences for human 5S rRNA
primers were 59-TACGGCCATACCACCCTGAA-39 and 59-
GCGGTCTCCCATCCAAGTAC-39. The sequences for human 7SK
RNA primers were 59-AGGACCGGTCTTCGGTCAA-39 and 59-
TCATTTGGATGTGTCTGCAGTCT-39. The sequences for human c-
Myc primers were 59-CGTCTCCACACATCAGCATAA-39 and 59-
GACACTGTCCAACTTGACCCTCTT-39. Relative transcript levels
were determined from the relative standard curve constructed from
stock cDNA dilutions and divided by the target quantity of the
calibrator following manufacturer’s instructions.
Anti-21A siRNA synthesis. The Anti-21A siRNA was synthesized
against a region of the 21A transcript of no homology with CENP-F so
that the silencing effect was speciﬁc for the pol III regulatory RNA
and did not interfere with CENP-F RNA stability. The siRNA synthesis
was carried out taking advantage of the siRNA construction kit
(Ambion, http://www.ambion.com) according to the manufacturer’s
protocol. The sense/antisense oligos used were: 59-aaGTGTGGTGG-
CTCACcctgtctc-39 and 59-aaGTGAGCCACCACACcctgtctc-39.
Proliferation assay. We tested proliferation of HeLa cells trans-
fected with 21A, 21A-1, 21A-2, 21A-3, and Anti-21A constructs plating
5310
5 cells per well in round-bottomed 96-well plates, incubated for
24, 48, and 72 h after transfection, and pulsed with [
3H]-thymidine
(1.0 lCi/10 ll/well) (Amersham Biosciences, http://www5.
amershambiosciences.com) for the last 18 h. We harvested the cells
and evaluated cell proliferation by counting the thymidine uptake.
We calculated the averaged proliferation rate, measured as counts
per minute, and standard deviation for the triplicate wells of each
sample.
RNA isolation and Northern blot analysis. Based on a single-step
acid-phenol–guanidium method, total RNA was extracted using
TRIzol reagent (Invitrogen) according to the manufacturer’s proto-
col. Total RNAs, from HeLa cells, were electrophoresed through 1.5%
agarose gels in the presence of formaldehyde and blotted onto
Hybond N membranes (Amersham). The blot was hybridized with an
85-bp–long probe contained in the region from nucleotide 1,194 to
nucleotide 1,278 of the 21A reported sequence (Table S2), spanning a
region internal to the transcript. The probe was obtained by PCR
(using the 21A plasmid construct as template) using the following
oligos: 21AF 59- GCTCACGTAGTCCCAGCACTTT-39 and 21AR 59-
AGACCAGCTTGGGCAACATAGT-39. Blot prehybridization was
performed at 65 8C for 2 h in 333 mM NaH2PO4 (pH 7.2), 6.66%
sodium dodecyl sulphate, and 250 mg/ml denatured salmon sperm
DNA. Blot hybridization was performed at 65 8C for 18 h in the same
solution containing 10
6 counts per minute/ml of denatured and
labeled probes. After hybridization the blots were washed twice at 65
8C for 30 min in 0.2% sodium dodecyl sulphate, 23SSPE and once at
65 8C for 30 min in 0.2% sodium dodecyl sulphate, and 0.23 SSPE.
Membranes were exposed to autoradiographic ﬁlms for 24–48 h and
then developed.
Western blot analysis. Equal amounts of proteins (10 lg/sample)
from each sample were loaded on standard 4%–12% NU-PAGE
gradient gels (Invitrogen). Blotting onto Protran nitrocellulose
membranes (Schleicher & Schuell, www.schleicher-schuell.com) was
performed in the X-Cell Sure Lock Electrophoresis Cell (Invitrogen),
according to the manufacturer’s instructions. The membranes were
saturated overnight in 3% nonfat milk in TTBS buffer (500 nM NaCl;
20 mM Tris/Cl [pH 7.5]; 0.05% Tween-20) and incubated for 4 h at
room temperature with the human anti-mitosin/CENP-F ab90
(ABCAM, http://abcam.com) and/or anti-alpha tubulin (OMIM
191110) (Sigma-Aldrich, www.sigmaaldrich.com) mouse monoclonal
antibodies. The anti-mitosin antibody recognized a weak signal at a
very high apparent molecular mass (350–400 kDa), while the anti-
alpha tubulin showed a clear signal at 45 kDa. The immunoreactive
band was revealed by an alkaline phosphate-conjugated afﬁnity-
puriﬁed monoclonal anti-rabbit–mouse IgG (Sigma-Aldrich), and (in
the experiment indicated in Figure 1C) the enzymatic chemilumi-
nescence (ECL) detection system (Amersham), or (in the experiment
indicated in Figure 1E) the alkaline phosphatase substrate BCIP/NBT
(ICN Biomedicals, http://www.mpbio.com).
Supporting Information
Table S1. Schematic Representation of PSE-TATA Box Distances
Found at doi:10.1371/journal.pgen.0030001.st001 (52 KB PPT).
Table S2. Table of Sequences
Found at doi:10.1371/journal.pgen.0030001.st002 (104 KB DOC).
Table S3. Putative Secondary Structures
Found at doi:10.1371/journal.pgen.0030001.st003 (429 KB PPT).
Table S4. Sequence Analysis by Repeat Masker
Found at doi:10.1371/journal.pgen.0030001.st004 (45 KB RTF).
Table S5. Transcription Unit Features
Found at doi:10.1371/journal.pgen.0030001.st005 (74 KB DOC).
Accession Numbers
The National Center for Biotechnology Information (http://www.ncbi.
nlm.nih.gov) accession numbers for the genes and gene products
discussed in this paper are: U6 (M14486), 7SK (001445), H1 (002312),
U2 (002716), CENP-F (016343), 5S rRNA (V00589), c-Myc (002467), and
GAPDH (002046).
Acknowledgments
We thank Silvio Garofalo and Lucio Luzzatto for helpful discussions
and suggestions. pSHAG vectors were obtained from Gregory
Hannon (Cold Spring Harbor Laboratory).
Author contributions. AP conceived and designed the experiments.
AP, MC, FT, and RF performed the experiments. AP, MC, FT, RF, GD,
PLoS Genetics | www.plosgenetics.org February 2007 | Volume 3 | Issue 2 | e1 0183
snRNA Gene-Like Regulatory Transcriptsand RC analyzed the data. AP, MC, FT, and RC contributed reagents/
materials/analysis tools. AP wrote the paper.
Funding. GD was supported by grants from the Human Frontier
Science Program (grant RGY0011/2002-C) and by the Italian Ministry
of Education, University and Research (MIUR, 2005 PRIN, and FIRB
Programs).
Competing interests. The authors have declared that no competing
interests exist.
References
1. Reis EM, Nakaya HI, Louro R, Canavez FC, Flatschart AV, et al. (2004)
Antisense intronic non-coding RNA levels correlate to the degree of tumor
differentiation in prostate cancer. Oncogene 23: 6684–6692.
2. Yelin R, Dahary D, Sorek R, Levanon EY, Goldstein O, et al. (2003)
Widespread occurrence of antisense transcription in the human genome.
Nat Biotechnol 21: 379–386.
3. Dahary D, Elroy-Stein O, Sorek R (2005) Naturally occurring antisense:
Transcriptional leakage or real overlap? Genome Res 15: 364–368.
4. Mattick JS (2004) RNA regulation: A new genetics? Nat Rev Genet 5: 316–
323.
5. Mattick JS, Makunin IV (2006) Non-coding RNA [review]. Hum Mol Genet
15: 17–29.
6. Ambros V (2004) The functions of animal microRNAs. Nature 431: 350–
355.
7. Lee Y, Kim M, Han J, Yeom KH, Lee S, et al. (2004) MicroRNA genes are
transcribed by RNA polymerase II. EMBO J 23: 4051–4060.
8. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, et al. (2005) The
transcriptional landscape of the mammalian genome. Science 309: 1559–
1563.
9. Levanon K, Eisenberg E, Rechavi G, Levanon EY (2005) Letter from the
editor: Adenosine-to-inosine RNA editing in Alu repeats in the human
genome [review]. EMBO Rep 6: 831–835.
10. Sorek R, Ast G, Graur D (2002) Alu-containing exons are alternatively
spliced. Genome Res 12: 1060–1067.
11. Sen SK, Han K, Wang J, Lee J, Wang H, et al. (2006) Human genomic
deletions mediated by recombination between Alu elements. Am J Hum
Genet 79: 41–53.
12. Stuart JJ, Egry LA, Wong GH, Kaspar RL (2000) The 39 UTR of human
MnSOD mRNA hybridizes to a small cytoplasmic RNA and inhibits gene
expression. Biochem Biophys Res Commun 27: 641–648.
13. Liu WM, Chu WM, Choudary PV, Schmid CW (1995) Cell stress and
translational inhibitors transiently increase the abundance of mammalian
SINE transcripts. Nucleic Acids Res 23: 1758–1765.
14. Smalheiser NR, Torvik VI (2006) Alu elements within human mRNAs are
probable microRNA targets. Trends Genet 22: 532–536.
15. Schramm L, Hernandez N (2002) Recruitment of RNA polymerase III to its
target promoters. Genes Dev 16: 2593–2620.
16. Myslinski E, Ame JC, Krol A, Carbon P (2001) An unusually compact
external promoter for RNA polymerase III transcription of the human
H1RNA gene. Nucleic Acids Res 29: 2502–2509.
17. Lobo SM, Iﬁll S, Hernandez N (1990) Cis-acting elements required for RNA
polymerase II and III transcription in the human U2 and U6 snRNA
promoters. Nucleic Acids Res 18: 2891–2899.
18. Mattaj IW, Dathan NA, Parry HD, Carbon P, Krol A (1988) Changing the
RNA polymerase speciﬁcity of U snRNA gene promoters. Cell 55: 435–442.
19. Cozzarelli NR, Gerrard SP, Schlissel M, Brown DD, Bogenhagen DF (1983)
Puriﬁed RNA polymerase III accurately and efﬁciently terminates tran-
scription of 5S RNA genes. Cell 34: 829–835.
20. Braglia P, Percudani R, Dieci G (2005) Sequence context effects on oligo
(dT) termination signal recognition by Saccharomyces cerevisiae RNA
polymerase III. J Biol Chem 280: 19551–19562.
21. Mathews DH, Sabina J, Zuker M, Turner DH (1999) Expanded sequence
dependence of thermodynamic parameters improves prediction of RNA
secondary structure. J Mol Biol 288: 911–940.
22. Liao H, Winkfein RJ, Mack G, Rattner JB, Yen TJ (1995) CENP-F is a protein
of the nuclear matrix that assembles onto kinetochores at late G2 and is
rapidly degraded after mitosis. J Cell Biol 130: 507–518.
23. Gilbert N, Labuda D (1999) CORE-SINEs: Eukaryotic short interspersed
retroposing elements with common sequence motifs. Proc Natl Acad Sci U
S A 96: 2869–2874.
24. Paolella G, Lucero MA, Murphy MH, Baralle FE. (1983) The Alu family
repeat promoter has a tRNA-like bipartite structure. EMBO J 2: 691–696.
25. Wu L, Pan J, Thoroddsen V, Wysong DR, Blackman RK, et al. (2003) Novel
small-molecule inhibitors of RNA polymerase III. Eukaryot Cell 2: 256–264.
26. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L (2005) Combinatorial
microRNA target predictions. Nat Genet 37: 495–500.
PLoS Genetics | www.plosgenetics.org February 2007 | Volume 3 | Issue 2 | e1 0184
snRNA Gene-Like Regulatory Transcripts